|
CRTC3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.33009999967204E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.67190003455653E-09 |
| Normal-vs-Stage2 |
8.776000E-02 |
| Normal-vs-Stage3 |
1.058220E-03 |
| Normal-vs-Stage4 |
1.128230E-01 |
| Stage1-vs-Stage2 |
2.680200E-02 |
| Stage1-vs-Stage3 |
3.617800E-02 |
| Stage1-vs-Stage4 |
1.923970E-03 |
| Stage2-vs-Stage3 |
4.878600E-01 |
| Stage2-vs-Stage4 |
7.116400E-01 |
| Stage3-vs-Stage4 |
2.041600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.63040000003656E-07 |
| Normal-vs-AfricanAmerican |
8.253800E-02 |
| Normal-vs-Asian |
2.173800E-01 |
| Caucasian-vs-AfricanAmerican |
2.354800E-01 |
| Caucasian-vs-Asian |
5.846200E-01 |
| AfricanAmerican-vs-Asian |
4.105200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.31360000005443E-06 |
| Normal-vs-Female |
3.46640000004061E-06 |
| Male-vs-Female |
6.237600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.945800E-02 |
| Normal-vs-Age(41-60Yrs) |
4.79460000035736E-07 |
| Normal-vs-Age(61-80Yrs) |
3.69420000000398E-05 |
| Normal-vs-Age(81-100Yrs) |
4.211600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.778200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.667000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.280600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.511000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.510610E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.915200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.78240000003882E-06 |
| Normal-vs-Grade 2 |
8.35949975908079E-10 |
| Normal-vs-Grade 3 |
8.391300E-04 |
| Normal-vs-Grade 4 |
2.966800E-01 |
| Grade 1-vs-Grade 2 |
2.840600E-01 |
| Grade 1-vs-Grade 3 |
2.037700E-02 |
| Grade 1-vs-Grade 4 |
1.076100E-03 |
| Grade 2-vs-Grade 3 |
1.702700E-03 |
| Grade 2-vs-Grade 4 |
2.32049999999706E-05 |
| Grade 3-vs-Grade 4 |
9.012500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.9169110743178E-12 |
| Normal-vs-ccB subtype |
8.423400E-03 |
| ccA subtype-vs-ccB subtype |
9.72229999951502E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.42690000000057E-05 |
| Normal-vs-N1 |
7.309000E-01 |
| N0-vs-N1 |
2.316600E-01 |
|
|
